Clovis Oncology, Inc. Lease, Cost
Clovis Oncology, Inc. reported Lease, Cost of $1.86 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-11-09
- Clovis Oncology, Inc. lease, cost for the quarter ending 2022-09-30 was $1.86M, a 1.79% decline year-over-year.
- Clovis Oncology, Inc. lease, cost for the quarter ending 2022-06-30 was $1.92M, a 27.60% decline year-over-year.
- Clovis Oncology, Inc. lease, cost for the quarter ending 2022-03-31 was $1.93M, a 23.22% decline year-over-year.
- Clovis Oncology, Inc. lease, cost for the quarter ending 2021-12-31 was $1.98M, a 20.93% decline year-over-year.
- Clovis Oncology, Inc. lease, cost for fiscal 2021 was $9.05M, a 7.99% decline from fiscal 2020.
- Clovis Oncology, Inc. lease, cost for fiscal 2020 was $9.83M, a 6.61% increase from fiscal 2019.
- Clovis Oncology, Inc. lease, cost for fiscal 2019 was $9.22M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.86M 10-Q · filed 2022-11-09 | $3.79M derived: sum of 2 quarters · filed 2022-11-09 | $5.72M 10-Q · filed 2022-11-09 | $7.70M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $1.92M 10-Q · filed 2022-08-08 | $3.85M 10-Q · filed 2022-08-08 | $5.83M derived: sum of 3 quarters · filed 2022-08-08 | $7.73M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $1.93M 10-Q · filed 2022-05-05 | $3.91M derived: sum of 2 quarters · filed 2022-05-05 | $5.81M derived: sum of 3 quarters · filed 2022-11-09 | $8.46M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.88M derived: sum of 2 quarters · filed 2022-11-09 | $6.53M derived: sum of 3 quarters · filed 2022-11-09 | $9.05M 10-K · filed 2022-02-24 |
| 2021-09-30 | $1.90M 10-Q · filed 2022-11-09 | $4.55M derived: sum of 2 quarters · filed 2022-11-09 | $7.07M 10-Q · filed 2022-11-09 | $9.57M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.65M 10-Q · filed 2022-08-08 | $5.17M 10-Q · filed 2022-08-08 | $7.67M derived: sum of 3 quarters · filed 2022-08-08 | $10.21M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.52M 10-Q · filed 2022-05-05 | $5.02M derived: sum of 2 quarters · filed 2022-05-05 | $7.56M derived: sum of 3 quarters · filed 2022-05-05 | $9.83M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $5.04M derived: sum of 2 quarters · filed 2022-02-24 | $7.31M derived: sum of 3 quarters · filed 2022-02-24 | $9.83M 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.54M 10-Q · filed 2021-11-03 | $4.81M derived: sum of 2 quarters · filed 2021-11-03 | $7.33M 10-Q · filed 2021-11-03 | $10.21M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $2.27M 10-Q · filed 2021-08-04 | $4.79M 10-Q · filed 2021-08-04 | $7.67M derived: sum of 3 quarters · filed 2021-08-04 | $9.32M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.52M 10-Q · filed 2021-05-05 | $5.40M derived: sum of 2 quarters · filed 2021-05-05 | $7.05M derived: sum of 3 quarters · filed 2021-05-05 | $9.28M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.54M derived: sum of 2 quarters · filed 2021-02-25 | $6.76M derived: sum of 3 quarters · filed 2021-02-25 | $9.22M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.66M 10-Q · filed 2020-11-05 | $3.88M derived: sum of 2 quarters · filed 2020-11-05 | $6.34M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.22M 10-Q · filed 2020-08-07 | $4.68M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $2.46M 10-Q · filed 2020-05-06 |